Company / Operating Cash Flow per Share
Sonoma Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.05
FY2026
5-year range
-$3.07 / -$0.05
FY2022-FY2026
Trend
+98.2%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-18.14 in FY2019 to $-0.05 in FY2026.
Based on SEC 10-K filings.
-0.05 in FY2026.
Improved from $-1.25 to $-0.05 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2026, operating cash flow per share increased 98.2% year-over-year.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | -$0.05 | +98.2% |
| FY2025 | -$3.07 | -146.4% |
| FY2024 | -$1.25 | +9.0% |
| FY2023 | -$1.37 | +15.1% |
| FY2022 | -$1.61 | +37.5% |
| FY2021 | -$2.58 | +71.0% |
| FY2020 | -$8.90 | +50.9% |
| FY2019 | -$18.14 | -852.7% |
| FY2018 | -$1.90 | +8.6% |
| FY2017 | -$2.08 | -368.4% |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026